Literature DB >> 7411415

Pharmacokinetics of nicotine in rats after single-cigarette smoke inhalation.

K S Rotenberg, R P Miller, J Adir.   

Abstract

The amount of nicotine absorbed following cigarette smoke inhalation was evaluated by comparing the area under the plasma concentration--time curve and urinary recovery with those observed after its intravenous injection to rats. Nicotine was adsorbed rapidly, with the maximum plasma concentration occurring immediately after cessation of cigarette smoke exposure. On the average, 68% of the nicotine delivered to the inhalation chamber was absorbed. The absorption and elimination of nicotine, as well as the formation and elimination of its metabolites, followed first-order kinetics, and the derived pharmacokinetic parameters were similar to those observed after the intravenous administration of nicotine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7411415     DOI: 10.1002/jps.2600690927

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation.

Authors:  Cyril V Abobo; Jing Ma; Dong Liang
Journal:  Nicotine Tob Res       Date:  2012-02-06       Impact factor: 4.244

2.  Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats.

Authors:  M Pravetoni; D E Keyler; M D Raleigh; A C Harris; M G Lesage; C K Mattson; S Pettersson; P R Pentel
Journal:  Biochem Pharmacol       Date:  2011-02-17       Impact factor: 5.858

3.  Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats.

Authors:  Andrew C Harris; Christina Mattson; Mark G Lesage; Daniel E Keyler; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2010-05-18       Impact factor: 3.533

4.  A rat model of cigarette smoke abuse liability.

Authors:  Petros Ypsilantis; Maria Politou; Constantinos Anagnostopoulos; Alexandros Kortsaris; Constantinos Simopoulos
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.